Esomeprazole-induced rhabdomyolysis in a patient with heart failure
- 254 Downloads
A 75-year-old male patient with chronic heart failure underwent aortic valve replacement and coronary artery bypass surgery and was transferred to our intensive care unit. He also suffered from renal failure and diabetes mellitus. He was sedated initially by propofol and sufentanil for mechanical ventilation. Other medications were insulin, heparin (800 IU/h), furosemide (40–120 mg/day), amiodarone (36 mg/h), meropenem (2 g/day), linezolid (1,200 mg/day) and catecholamines. Intravenous esomeprazole was administered (40–80 mg/day) for stress ulcer prophylaxis. Furthermore, the patient was treated with continuous veno-venous haemofiltration for 12 days.
After the successful surgery procedure, alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT) and the C-reactive protein (CRP) levels decreased, but myoglobin remained elevated. After excluding several clinical reasons, the most probable drugs known to cause rhabdomyolysis—propofol and amiodaron—were discontinued....
KeywordsProton Pump Inhibitor Linezolid Sufentanil Esomeprazole Stress Ulcer
Conflict of interest statement
We certify that there is no actual or potential conflict of interest in relation to this article.
- 5.Wilder-Smith CH, Bondarov P, Lundgren M, Niazi M, Röhss K, Ahlbom H, Nyman L (2005) Intravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies. Eur J Gastroenterol Hepatol 17:191–197CrossRefPubMedGoogle Scholar
- 7.Schönhöfer PS, Werner B, Tröger U (1997) Ocular damage associated with proton pump inhibitors. Br Med J 314:1805Google Scholar